Market Overview

UPDATE: Benchmark Initiates Coverage on IMAX on Near-Term Optimism, Ongoing Performance Risk

Share:
Related IMAX
Netflix, HBO Now And More: What Wedbush Analysts Are Watching
IMAX's Record April Debut: 'Furious 7' Grosses $20.8M Globally In IMAX Theatres

In a report published Wednesday, Benchmark Company analyst Mike Hickey initiated coverage on IMAX Corporation (NYSE: IMAX) with a Hold rating and $29.42 price target.

In the report, Benchmark Company noted, “We remain optimistic near term over the IMAX brand and premium ticket experience they offer to a rapidly unfolding international growth opportunity. We remain cautious over the Company's ongoing performance risk, particularly over a network growth scenario that appears to have slowed meaningfully. We believe both fiscal Q3'13 and Q4'13 financial performance could disappoint street consensus, offset somewhat by a meaningful reduction in street consensus for their fiscal Q3'13 period, as box office performance greatly disappointed original expectations.”

IMAX Corporation closed on Tuesday at $29.70.

Latest Ratings for IMAX

DateFirmActionFromTo
Apr 2015Canaccord GenuityUpgradesHoldBuy
Apr 2015MacquarieInitiates Coverage onOutperform
Feb 2015Canaccord GenuityDowngradesBuyHold

View More Analyst Ratings for IMAX
View the Latest Analyst Ratings

Posted-In: Benchmark Company Mike HickeyAnalyst Color Initiation Analyst Ratings

 

Related Articles (IMAX)

Around the Web, We're Loving...